medica 16 has been researched along with hydroxycitric acid in 2 studies
| Studies (medica 16) | Trials (medica 16) | Recent Studies (post-2010) (medica 16) | Studies (hydroxycitric acid) | Trials (hydroxycitric acid) | Recent Studies (post-2010) (hydroxycitric acid) |
|---|---|---|---|---|---|
| 35 | 0 | 4 | 7 | 0 | 3 |
| Protein | Taxonomy | medica 16 (IC50) | hydroxycitric acid (IC50) |
|---|---|---|---|
| ATP-citrate synthase | Homo sapiens (human) | 0.15 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abramson, HN | 1 |
| Granchi, C | 1 |
1 review(s) available for medica 16 and hydroxycitric acid
| Article | Year |
|---|---|
ATP citrate lyase (ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism.
Topics: Antineoplastic Agents; ATP Citrate (pro-S)-Lyase; Dose-Response Relationship, Drug; Glucose; Humans; Lipid Metabolism; Molecular Structure; Neoplasms; Structure-Activity Relationship | 2018 |
1 other study(ies) available for medica 16 and hydroxycitric acid
| Article | Year |
|---|---|
The lipogenesis pathway as a cancer target.
Topics: Acetyl-CoA Carboxylase; Animals; Antineoplastic Agents; ATP Citrate (pro-S)-Lyase; Biosynthetic Pathways; Fatty Acid Synthases; Fatty Acids; Humans; Lipogenesis; Models, Chemical; Molecular Structure; Neoplasms | 2011 |